What is the main business of Polfaclinic?

The main business activity of Polfaclinic focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 4, 2012.

Where is the headquarters located?

The headquarters is located at: ul. Przyjacielska 110, 05-230 Kobyłka.

What is the share capital?

The share capital of the company is PLN 25,000 (approx. $6,753).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $62,980, representing a decrease of 42.3% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $2,500, meaning the company decreased its profit by 81.8%.

What is the main operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $43,203 in 2024, representing 74% of all operating expenses.

Polfaclinicsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2012-10-04

Share capital

25,000.00 PLN

Registered address

ul. Przyjacielska 110/2, 05-230 Kobyłka, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 1 of 6 financial statements not filed.

2025not filed
202411/07/2025
202315/07/2024
202204/07/2023
2021not filed
202011/05/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Manufacture of pharmaceutical preparations195 / 258

Top 76%

Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations241 / 330

Top 73%

Sector · Manufacturing26,533 / 33,745

Top 79%

Voivodeship · Mazowieckie88,419 / 142,031

Top 62%

Country · Poland318,242 / 495,850

Top 64%

Results vs industry

Revenue

This companyUSD 62.98kMedianUSD 919.05kAverageUSD 25.83m

Net profit

This companyUSD 2.50kMedianUSD 14.92kAverageUSD 2.77m

Operating costs

This companyUSD 58.34kMedianUSD 873.06kAverageUSD 21.43m

Assets

This companyUSD 34.37kMedianUSD 897.46kAverageUSD 31.52m

Industry

Trademarks

Polfaclinic holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2021.

Mark	Number	Classes	Status	Protected until
POLFACLINIC(word)	Z.529885	3, 5, 35	Protected	Jun 2, 2031

Mark	Protected until
POLFACLINIC(word)	Jun 2, 2031

Authorized Representatives

Andrzej Piotr Jakubowski – Attorney-in-fact

Grzegorz Maciej Dworak – President of the Management Board

Manner of representation

In the case of a one-person management board, the President of the Management Board acts independently. In the case of a multi-member management board, the President of the Management Board acts jointly with a member of the management board, or a member of the management board acts jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Anna Małgorzata Dworakage 43	200	$2,701.24	40%
Andrzej Piotr Jakubowskiage 57	300	$4,051.86	60%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2015-10-23.

Alior Bank
54 2490 0005 0000 4600 4679 0023
Alior Bank
75 2490 0005 0000 4530 5143 6086

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication date	Event
Apr 12, 2017	Liquidation opened

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
BiotonS.A.	$72,911,351.08	bioton.com
Celon PharmaS.A.	$52,550,739.16	celonpharma.com
VercoS.A.	$43,577,172.02	verco.com.pl
VipharmS.A.	$30,660,173.61	vipharm.pl
MedicofarmaS.A.	$8,530,473.72	medicofarma.pl
VitamaS.A.	$4,287,087.38	vitama.pl
Munar PharmaS.A.	$85,649.72	munar.pl
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com

Change history

Date	Event
2024-04-15	Address change (Ul. Czerniakowska 71/407b, 00-715, Warszawa → Ul. Przyjacielska 110/2, 05-230, Kobyłka)
2022-11-30	Address change (Ul. Czerniakowska 71/112, 00-715, Warszawa → Ul. Czerniakowska 71/407b, 00-715, Warszawa)
2022-11-30	Share capital increase (5,000.00 PLN → 25,000.00 PLN)
2022-11-30	PKD change (Removed: 8 codes; Added: 8 codes)
2019-06-04	Address change (Ul. Chełmska 30-34/231b, 00-725, Warszawa → Ul. Czerniakowska 71/112, 00-715, Warszawa)

FAQ

Last updated: 2026-04-24